WebEx link: https://uwhealth.webex.com/uwhealth/j.php?MTID=mab39408d52af83f46b7cf183880ef0b1
3 parts - Each session will consist of 15 minutes of content with 5 minutes for questions and feedback for a total of 60 minutes. 

GLP-1 Agonists: The Missing Puzzle Piece in NAFLD? - Ethan Meyer, DPH-4 Student

• Objectives 
  1. Explain the pathophysiology and treatment of NAFLD 
  2. Identify relevant studies and active clinical trials evaluating the use of GLP-1 agonists in treatment of NAFLD 
  3. Discuss the future outlook for screening and treatment of NAFLD

EVUSHELD for Pre-Exposure Prophylaxis Against COVID-19 in Immunocompromised Patients - Monica Ruh, DPH-4 Student

• Objectives 
  1. Define and summarize what EVUSHELD is and how it is administered 
  2. Interpret the Emergency Use Authorization for EVUSHELD 
  3. Determine which patients are eligible to receive EVUSHELD 
  4. Analyze clinical trial results to understand results and adverse effects ​​​​​​

Suboxone Overview - Amrita Geddam, DPH-4 Student 

• Objectives 
  1. Define and outline the unique characteristics of buprenorphine which allows it to be an effective OUD agent 
  2. Identify and recognize the changes being made to the X-waiver and how this can impact future pharmacist practice 
  3. Compare and contrast the differences between outpatient and inpatient initiation of buprenorphine products like buprenorphine